Biographical Sketch
John Suh, MD, is the Chairman of the Department of Radiation Oncology and Associate Director of the Gamma Knife Center at the Brain Tumor and Neuro-Oncology Center at Cleveland Clinic.
Dr. Suh received his Bachelor's and Medical degrees from the University of Miami School of Medicine in Miami, Fla. He completed his internship, residency and fellowship at Cleveland Clinic from 1990 to 1995 and joined the Staff in 1995. He was the Residency Program Director from 1996 to 2002.
Dr. Suh is a written and oral Board Examiner for the American Board of Radiology. He serves as a reviewer for various medical journals and is a member of various medical societies.
His primary research interests are brain tumors, Gamma Knife radiosurgery and innovative radiation modalities. He has participated in numerous in-house, pharmaceutical and cooperative group trials.
Specialty Interests
adult and pediatric brain and spine tumors, adult and pediatric brain tumors, adult and pediatric neuro-oncology, benign and malignant tumors of the brain and spinal cord, benign brain tumors (meningiomas, schwannomas), Brain Metastases, brain tumors, CNS metastatic disease, gamma knife, gamma knife and radiosurgery, Gamma Knife Radiosurgery, immunotherapy, intensity-modulated radiation therapy, Meningiomas, pediatric radiotherapy, radiation sensitizers, Spinal Radiosurgery, spine radiosurgery, tumors of the brain and spine, spinal radiosurgery
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 10/5/2008, Dr.
Suh has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Suh receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Medtronic, Inc.
